---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-262589"
form_type: "8-K"
ticker: "RCUS"
cik: "0001724521"
company_name: "Arcus Biosciences, Inc."
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:54:43.004805+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcus Biosciences closes public offering of 15.76M shares, net proceeds ~$269.7M

## Summary
- Sold 15,755,000 shares at $18.25 per share including full exercise of underwriters' option.
- Net proceeds of approximately $269.7 million after discounts and estimated expenses.
- Underwriters led by Leerink Partners LLC and Goldman Sachs & Co. LLC.
- Offering closed on November 3, 2025.

## SEC filing metadata
- accession: 0001193125-25-262589
- form_type: 8-K
- ticker: RCUS
- cik: 0001724521
- company_name: Arcus Biosciences, Inc.
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1724521/000119312525262589/0001193125-25-262589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1724521/000119312525262589/d912891d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-262589
- JSON: https://secwatch.observer/filing/0001193125-25-262589.json
- Plain text: https://secwatch.observer/filing/0001193125-25-262589.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.